Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource, 1 online resource.
Sprache
Englisch

Erschienen in
Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer ; volume:50 ; number:9 ; day:6 ; month:5 ; year:2023 ; pages:2899-2909 ; date:7.2023
European journal of nuclear medicine and molecular imaging ; 50, Heft 9 (6.5.2023), 2899-2909, 7.2023

Urheber
Rosar, Florian
Khreish, Fadi
Marlowe, Robert J.
Schaefer-Schuler, Andrea
Burgard, Caroline
Maus, Stephan
Petto, Sven
Bartholomä, Mark
Ezziddin, Samer
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s00259-023-06241-0
URN
urn:nbn:de:101:1-2023093011345452009620
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:02 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

Ähnliche Objekte (12)

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma

68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA-11 PET/CT mit low-dose CT : Diagnostischer Zugewinn durch minimale kontrastmittelgestützte Urographie

68Ga-PSMA-11 PET/CT mit low-dose CT : Diagnostischer Zugewinn durch minimale kontrastmittelgestützte Urographie

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom

Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Verbundene Objekte